Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System

The enclosed work focuses on the construction variables associated with a dual-antigen liposomal carrier, delivering encapsulated polysaccharides and surface-localized proteins, which served as a vaccine delivery device effective against pneumococcal disease. Here, the goal was to better characteriz...

Full description

Bibliographic Details
Main Authors: Roozbeh Nayerhoda, Andrew Hill, Marie Beitelshees, Charles Jones, Blaine Pfeifer
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Materials
Subjects:
Online Access:https://www.mdpi.com/1996-1944/12/17/2809
id doaj-658b422b878d4ed9b6a8485587945fca
record_format Article
spelling doaj-658b422b878d4ed9b6a8485587945fca2020-11-25T01:39:51ZengMDPI AGMaterials1996-19442019-09-011217280910.3390/ma12172809ma12172809Design Variation of a Dual-Antigen Liposomal Vaccine Carrier SystemRoozbeh Nayerhoda0Andrew Hill1Marie Beitelshees2Charles Jones3Blaine Pfeifer4Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USADepartment of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USADepartment of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USAAbcombi Biosciences Inc., 1576 Sweet Home Road, Amherst, NY 14228, USADepartment of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USAThe enclosed work focuses on the construction variables associated with a dual-antigen liposomal carrier, delivering encapsulated polysaccharides and surface-localized proteins, which served as a vaccine delivery device effective against pneumococcal disease. Here, the goal was to better characterize and compare the carrier across a range of formulation steps and assessment metrics. Specifically, the vaccine carrier was subjected to new methods of liposomal formation, including alterations to the base components used for subsequent macromolecule encapsulation and surface attachment, with characterization spanning polysaccharide encapsulation, liposomal size and charge, and surface protein localization. Results demonstrate variations across the liposomal constructs comprised two means of surface-localizing proteins (either via metal or biological affinity). In general, final liposomal constructs demonstrated a size and zeta potential range of approximately 50 to 600 nm and −4 to −41 mV, respectively, while demonstrating at least 60% polysaccharide encapsulation efficiency and 60% protein surface localization for top-performing liposomal carrier constructs. The results, thus, indicate that multiple formulations could serve in support of vaccination studies, and that the selection of a suitable final delivery system would be dictated by preferences or requirements linked to target antigens and/or regulatory demands.https://www.mdpi.com/1996-1944/12/17/2809liposomeencapsulationdeliveryvaccinepneumococcal disease
collection DOAJ
language English
format Article
sources DOAJ
author Roozbeh Nayerhoda
Andrew Hill
Marie Beitelshees
Charles Jones
Blaine Pfeifer
spellingShingle Roozbeh Nayerhoda
Andrew Hill
Marie Beitelshees
Charles Jones
Blaine Pfeifer
Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
Materials
liposome
encapsulation
delivery
vaccine
pneumococcal disease
author_facet Roozbeh Nayerhoda
Andrew Hill
Marie Beitelshees
Charles Jones
Blaine Pfeifer
author_sort Roozbeh Nayerhoda
title Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
title_short Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
title_full Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
title_fullStr Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
title_full_unstemmed Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
title_sort design variation of a dual-antigen liposomal vaccine carrier system
publisher MDPI AG
series Materials
issn 1996-1944
publishDate 2019-09-01
description The enclosed work focuses on the construction variables associated with a dual-antigen liposomal carrier, delivering encapsulated polysaccharides and surface-localized proteins, which served as a vaccine delivery device effective against pneumococcal disease. Here, the goal was to better characterize and compare the carrier across a range of formulation steps and assessment metrics. Specifically, the vaccine carrier was subjected to new methods of liposomal formation, including alterations to the base components used for subsequent macromolecule encapsulation and surface attachment, with characterization spanning polysaccharide encapsulation, liposomal size and charge, and surface protein localization. Results demonstrate variations across the liposomal constructs comprised two means of surface-localizing proteins (either via metal or biological affinity). In general, final liposomal constructs demonstrated a size and zeta potential range of approximately 50 to 600 nm and −4 to −41 mV, respectively, while demonstrating at least 60% polysaccharide encapsulation efficiency and 60% protein surface localization for top-performing liposomal carrier constructs. The results, thus, indicate that multiple formulations could serve in support of vaccination studies, and that the selection of a suitable final delivery system would be dictated by preferences or requirements linked to target antigens and/or regulatory demands.
topic liposome
encapsulation
delivery
vaccine
pneumococcal disease
url https://www.mdpi.com/1996-1944/12/17/2809
work_keys_str_mv AT roozbehnayerhoda designvariationofadualantigenliposomalvaccinecarriersystem
AT andrewhill designvariationofadualantigenliposomalvaccinecarriersystem
AT mariebeitelshees designvariationofadualantigenliposomalvaccinecarriersystem
AT charlesjones designvariationofadualantigenliposomalvaccinecarriersystem
AT blainepfeifer designvariationofadualantigenliposomalvaccinecarriersystem
_version_ 1725048713495183360